These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
790 related items for PubMed ID: 28882412
1. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS. Stagni F, Giacomini A, Guidi S, Emili M, Uguagliati B, Salvalai ME, Bortolotto V, Grilli M, Rimondini R, Bartesaghi R. Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412 [Abstract] [Full Text] [Related]
2. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome. Stagni F, Giacomini A, Emili M, Trazzi S, Guidi S, Sassi M, Ciani E, Rimondini R, Bartesaghi R. Neuroscience; 2016 Oct 01; 333():277-301. PubMed ID: 27457036 [Abstract] [Full Text] [Related]
3. The flavonoid 7,8-DHF fosters prenatal brain proliferation potency in a mouse model of Down syndrome. Stagni F, Uguagliati B, Emili M, Giacomini A, Bartesaghi R, Guidi S. Sci Rep; 2021 Mar 18; 11(1):6300. PubMed ID: 33737521 [Abstract] [Full Text] [Related]
4. Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome. Parrini M, Ghezzi D, Deidda G, Medrihan L, Castroflorio E, Alberti M, Baldelli P, Cancedda L, Contestabile A. Sci Rep; 2017 Dec 04; 7(1):16825. PubMed ID: 29203796 [Abstract] [Full Text] [Related]
5. Treatment with corn oil improves neurogenesis and cognitive performance in the Ts65Dn mouse model of Down syndrome. Giacomini A, Stagni F, Emili M, Guidi S, Salvalai ME, Grilli M, Vidal-Sanchez V, Martinez-Cué C, Bartesaghi R. Brain Res Bull; 2018 Jun 04; 140():378-391. PubMed ID: 29935232 [Abstract] [Full Text] [Related]
6. Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. Bianchi P, Ciani E, Guidi S, Trazzi S, Felice D, Grossi G, Fernandez M, Giuliani A, Calzà L, Bartesaghi R. J Neurosci; 2010 Jun 30; 30(26):8769-79. PubMed ID: 20592198 [Abstract] [Full Text] [Related]
7. Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome. Emili M, Stagni F, Salvalai ME, Uguagliati B, Giacomini A, Albac C, Potier MC, Grilli M, Bartesaghi R, Guidi S. Neurobiol Dis; 2020 Jul 30; 140():104874. PubMed ID: 32325119 [Abstract] [Full Text] [Related]
8. Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome. Stagni F, Raspanti A, Giacomini A, Guidi S, Emili M, Ciani E, Giuliani A, Bighinati A, Calzà L, Magistretti J, Bartesaghi R. Neurobiol Dis; 2017 Jul 30; 103():11-23. PubMed ID: 28359846 [Abstract] [Full Text] [Related]
12. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice. Stagni F, Giacomini A, Guidi S, Ciani E, Ragazzi E, Filonzi M, De Iasio R, Rimondini R, Bartesaghi R. Neurobiol Dis; 2015 Feb 30; 74():204-18. PubMed ID: 25497735 [Abstract] [Full Text] [Related]
13. Propofol exposure during late stages of pregnancy impairs learning and memory in rat offspring via the BDNF-TrkB signalling pathway. Zhong L, Luo F, Zhao W, Feng Y, Wu L, Lin J, Liu T, Wang S, You X, Zhang W. J Cell Mol Med; 2016 Oct 30; 20(10):1920-31. PubMed ID: 27297627 [Abstract] [Full Text] [Related]
14. 7,8-Dihydroxyflavone leads to survival of cultured embryonic motoneurons by activating intracellular signaling pathways. Tsai T, Klausmeyer A, Conrad R, Gottschling C, Leo M, Faissner A, Wiese S. Mol Cell Neurosci; 2013 Sep 30; 56():18-28. PubMed ID: 23500004 [Abstract] [Full Text] [Related]
15. Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation. Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, Li SX, Shirayama Y, Hashimoto K. Int J Neuropsychopharmacol; 2014 Oct 31; 18(4):. PubMed ID: 25628381 [Abstract] [Full Text] [Related]
16. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model. Guidi S, Stagni F, Bianchi P, Ciani E, Giacomini A, De Franceschi M, Moldrich R, Kurniawan N, Mardon K, Giuliani A, Calzà L, Bartesaghi R. Brain; 2014 Feb 31; 137(Pt 2):380-401. PubMed ID: 24334313 [Abstract] [Full Text] [Related]
17. Reversal of neurodevelopmental impairment and cognitive enhancement by pharmacological intervention with the polyphenol polydatin in a Down syndrome model. Emili M, Stagni F, Russo C, Angelozzi L, Guidi S, Bartesaghi R. Neuropharmacology; 2024 Dec 15; 261():110170. PubMed ID: 39341334 [Abstract] [Full Text] [Related]
18. The Small-Molecule TrkB Agonist 7, 8-Dihydroxyflavone Decreases Hippocampal Newborn Neuron Death After Traumatic Brain Injury. Chen L, Gao X, Zhao S, Hu W, Chen J. J Neuropathol Exp Neurol; 2015 Jun 15; 74(6):557-67. PubMed ID: 25933388 [Abstract] [Full Text] [Related]
19. Companions reverse stressor-induced decreases in neurogenesis and cocaine conditioning possibly by restoring BDNF and NGF levels in dentate gyrus. Tzeng WY, Chuang JY, Lin LC, Cherng CG, Lin KY, Chen LH, Su CC, Yu L. Psychoneuroendocrinology; 2013 Mar 15; 38(3):425-37. PubMed ID: 22832183 [Abstract] [Full Text] [Related]
20. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome. Uguagliati B, Al-Absi AR, Stagni F, Emili M, Giacomini A, Guidi S, Nyengaard JR, Bartesaghi R. Hippocampus; 2021 Apr 15; 31(4):435-447. PubMed ID: 33464704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]